Exactly. Only 3 occurrences will bring about a me
Post# of 148087
Quote:
Exactly.
Only 3 occurrences will bring about a meaningful increase.
1. Partnership
2. Buyout
3. Approval.
Trial results from mssCRC and especially the Alzheimer's pilot study could push the share price nicely. Biopharma investors are always looking for potential and want to get in cheap before a significant share price rise. Alzheimer's on the other hand could get mainstream media coverage and pull in a broader range of investors.